Satsuma Pharmaceuticals Inc (STSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | STSA | AMGN | BMY | VRTX | GILD |
| Company | Satsuma Pharmaceuticals Inc | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 1.1100 | 288.18 | 58.16 | 454.24 | 89.07 |
| High | 1.1400 | 290.57 | 58.48 | 455.43 | 89.94 |
| Low | 1.0100 | 284.14 | 57.47 | 445.00 | 88.07 |
| Last | 1.1000 | 290.79 | 58.24 | 450.26 | 89.65 |
| Change | -0.0100 | +2.92 | +0.36 | -0.97 | +1.02 |
| % Change | -0.90% | +1.01% | +0.62% | -0.21% | +1.15% |
| Volume | 1,829,700 | 1,709,907 | 4,348,610 | 812,991 | 2,067,444 |
| 20-Day Average Volume | 576,695 | 2,827,044 | 12,232,043 | 1,308,807 | 7,424,813 |
| Previous Close | 1.1100 | 287.87 | 57.88 | 451.23 | 88.63 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.0658 | 307.44 | 55.93 | 479.24 | 90.88 |
| 20-Day Raw Stochastic | 69.23% | 28.18% | 71.30% | 6.98% | 27.93% |
| 20-Day Relative Strength | 58.87% | 36.90% | 61.12% | 40.88% | 53.37% |
| Weighted Alpha | -14.90 | +2.17 | +26.61 | +18.05 | +25.87 |
| Today's Opinion | 8% Buy | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Previous Opinion | 8% Buy | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Last Month's Opinion | 8% Sell | 8% Buy | 88% Buy | 8% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.76% since 05/31/23 | -1.87% since 11/14/24 | -0.14% since 11/14/24 | -6.95% since 11/14/24 | -2.66% since 11/14/24 |
| Low | 1.0100 on 06/07/23 | 275.56 on 11/19/24 | 55.82 on 11/15/24 | 445.13 on 11/21/24 | 86.08 on 11/19/24 |
| High | 1.1400 on 06/07/23 | 291.50 on 11/15/24 | 58.83 on 11/20/24 | 479.93 on 11/15/24 | 91.99 on 11/15/24 |
| 1-Month | |||||
| %Chg | +2.80% since 05/05/23 | -8.31% since 10/21/24 | +12.09% since 10/21/24 | -5.80% since 10/21/24 | +3.91% since 10/21/24 |
| Low | 1.0100 on 06/07/23 | 275.56 on 11/19/24 | 51.81 on 10/28/24 | 445.13 on 11/21/24 | 85.60 on 10/22/24 |
| High | 1.1400 on 06/07/23 | 328.25 on 11/08/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | +16.17% since 03/07/23 | -11.77% since 08/21/24 | +20.60% since 08/21/24 | -7.36% since 08/21/24 | +19.34% since 08/21/24 |
| Low | 0.6550 on 04/14/23 | 275.56 on 11/19/24 | 46.88 on 08/22/24 | 445.13 on 11/21/24 | 75.35 on 08/22/24 |
| High | 1.4700 on 04/17/23 | 339.17 on 09/23/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | +31.28% since 12/07/22 | -7.76% since 05/21/24 | +38.21% since 05/21/24 | +1.89% since 05/21/24 | +33.24% since 05/21/24 |
| Low | 0.6550 on 04/14/23 | 275.56 on 11/19/24 | 39.35 on 07/05/24 | 435.57 on 05/30/24 | 62.07 on 05/31/24 |
| High | 1.4700 on 04/17/23 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 36,467 | 154,739,632 | 117,390,888 | 116,204,808 | 110,456,552 |
| Shares Outstanding, K | 33,152 | 537,533 | 2,028,177 | 257,529 | 1,246,266 |
| Annual Sales | 0 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | -70,060,000 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 0 | 8,503,000,000 | 11,892,000,000 | 2,771,900,000 | 7,545,000,000 |
| Last Quarter Net Income | -10,290,000 | 2,830,000,000 | 1,211,000,000 | 1,045,400,000 | 1,253,000,000 |
| 60-Month Beta | 0.10 | 0.60 | 0.44 | 0.39 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.31 on 05/11/23 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 05/16/23 | 10/30/24 | 10/31/24 | 11/04/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | 03/28/14 | 11/18/24 | 10/04/24 | N/A | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.57 | 49.77 | 0.00 | 19.81 |